» Articles » PMID: 27423183

Genetic, Hormonal and Metabolic Aspects of PCOS: an Update

Overview
Publisher Biomed Central
Date 2016 Jul 18
PMID 27423183
Citations 154
Authors
Affiliations
Soon will be listed here.
Abstract

Polycystic ovary syndrome (PCOS) is a complex endocrine disorder affecting 5-10 % of women of reproductive age. It generally manifests with oligo/anovulatory cycles, hirsutism and polycystic ovaries, together with a considerable prevalence of insulin resistance. Although the aetiology of the syndrome is not completely understood yet, PCOS is considered a multifactorial disorder with various genetic, endocrine and environmental abnormalities. Moreover, PCOS patients have a higher risk of metabolic and cardiovascular diseases and their related morbidity, if compared to the general population.

Citing Articles

Integrated Transcriptome Analysis of lncRNA, miRNA, and mRNA Reveals key Regulatory Modules for Polycystic Ovary Syndrome.

Lin R, Zheng S, Su H, Wang G, Li X, Lu C Phenomics. 2025; 4(6):570-583.

PMID: 40061822 PMC: 11889321. DOI: 10.1007/s43657-024-00183-9.


Association of age at menarche and different causes of infertility: a retrospective study of 7634 women undergoing assisted reproductive technology.

Ban M, Jiao J, Zhou J, Cui L, Wang H, Chen Z J Ovarian Res. 2025; 18(1):40.

PMID: 40011967 PMC: 11863671. DOI: 10.1186/s13048-025-01629-y.


Does Magnesium Affect Sex Hormones and Cardiometabolic Risk Factors in Patients with PCOS? Findings from a Systematic Review and Meta-Analysis.

Abu-Zaid A, Alzayed M, Albahrani S, Almaqhawi A, Al Shaikh M, Baradwan S Medicina (Kaunas). 2025; 61(2).

PMID: 40005397 PMC: 11857371. DOI: 10.3390/medicina61020280.


Shortened Relative Leukocyte Telomere Length Is Associated With Polycystic Ovary Syndrome and Metabolic Traits.

Chan R, Huang C, Ng N, Tam H, Tam C, Cheng F Endocrinol Diabetes Metab. 2025; 8(2):e70030.

PMID: 39963020 PMC: 11833164. DOI: 10.1002/edm2.70030.


The role of LH in follicle development: from physiology to new clinical implications.

Longo M, Liuzzi F, De Carlini S, La Marca A Reprod Biol Endocrinol. 2025; 23(Suppl 1):22.

PMID: 39930391 PMC: 11808943. DOI: 10.1186/s12958-025-01353-8.


References
1.
Fauser B, Devroey P, Macklon N . Multiple birth resulting from ovarian stimulation for subfertility treatment. Lancet. 2005; 365(9473):1807-16. DOI: 10.1016/S0140-6736(05)66478-1. View

2.
Pinilla L, Aguilar E, Dieguez C, Millar R, Tena-Sempere M . Kisspeptins and reproduction: physiological roles and regulatory mechanisms. Physiol Rev. 2012; 92(3):1235-316. DOI: 10.1152/physrev.00037.2010. View

3.
Thomson R, Spedding S, Buckley J . Vitamin D in the aetiology and management of polycystic ovary syndrome. Clin Endocrinol (Oxf). 2012; 77(3):343-50. DOI: 10.1111/j.1365-2265.2012.04434.x. View

4.
Gaytan F, Gaytan M, Castellano J, Romero M, Roa J, Aparicio B . KiSS-1 in the mammalian ovary: distribution of kisspeptin in human and marmoset and alterations in KiSS-1 mRNA levels in a rat model of ovulatory dysfunction. Am J Physiol Endocrinol Metab. 2009; 296(3):E520-31. DOI: 10.1152/ajpendo.90895.2008. View

5.
Chen Z, Zhao H, He L, Shi Y, Qin Y, Shi Y . Genome-wide association study identifies susceptibility loci for polycystic ovary syndrome on chromosome 2p16.3, 2p21 and 9q33.3. Nat Genet. 2010; 43(1):55-9. DOI: 10.1038/ng.732. View